Clinical Laboratory Services Market – Europe is expected to account for higher market share of more than 35% driven due to the increasing the incidence of chronic disease conditions in the region: Global Market Analysis 2013 – 2017 and Forecast 2018 – 2024

Clinical Laboratory Services Market – Europe is expected to account for higher market share of more than 35% driven due to the increasing the incidence of chronic disease conditions in the region: Global Market Analysis 2013 – 2017 and Forecast 2018 – 2024

Market Scenario

Clinical Laboratory Services Market is expecting to grow at a faster rate in the forecast period due to factors including increasing demand for early detection of diseases, rising investments on the research and development of the clinical products, rising complications in the management of healthcare products, rising demand for innovative laboratory testing procedures of and rising need of places that speeds-up the process of healthcare research. However, concern regarding increasing cost may hamper the growth of clinical laboratory services market. Both the developed and developing countries are highly investing in the several types of clinical researches, thus, the demand for Clinical laboratory services is increasing from year to year. Additionally, rising healthcare centers and hospitals also drive the market for Clinical laboratory services. Europe had the highest market share in 2017, primarily due to increasing the incidence of chronic disease conditions in the region. Germany and U.K. hold the major share in this region due to increasing research and development activities. Other factors such as rising investment by the government on healthcare and the increasing number of clinical research centres in the region also drive the market for Clinical laboratory services through the forecast period. North America is expected to have a higher growth rate in the forecast period due to high awareness about early diagnosis, an increasing rate of lifestyle diseases, and the rising number of seasonal diseases in the region. U.S. and Canada held the major share in this region due to rising investment from the government and other private organizations for clinical research and development in the countries. Stand-alone laboratories had the highest market share in 2017, primarily due to a rising number of infectious diseases. Other factors including advancement in the laboratory technologies, increasing demand for quick results, and advancement in the test methodology in the stand-alone laboratories also drive the Clinical laboratory services. clinical laboratory services market

Clinical Laboratory Services Market Segmentation

Clinical Laboratory Services Market By Test Types

o Clinical Chemistry Testing  Routine Chemistry Testing  Endocrinology Chemistry Testing  Therapeutic Drug Monitoring (TDM) Testing  Specialized Chemistry Testing  Other Clinical Chemistry Testing o Microbiology Testing  Infectious Disease Testing  Transplant Diagnostic Testing  Other Microbiology Testing o Hematology Testing o Immunology Testing o Cytology Testing o Genetic Testing o Drug of Abuse Testing

• Clinical Laboratory Services Market By Provider

o Hospital-Based Laboratories o Stand-Alone Laboratories o Clinic-Based Laboratories

• Clinical Laboratory Services Market By Applications

o Drug discovery related Services o Drug development related services o Bio analytical & Lab chemistry services o Toxicology testing services o Cell & gene therapy related services o Preclinical & clinical trial related services o Other clinical laboratory services The above data will be provided for following regions/countries from 2013-2024 (USD Million) • North America o U.S. o Canada • Europe o Germany o UK o France o Spain o Italy • Asia Pacific o China o India o Japan o Australia • Latin America o Argentina o Brazil o Mexico • Middle East and Africa o South Africa o Saudi Arabia What information is covered in report? • Actual market numbers from 2013-2017, estimates and forecasts from 2018 to 2024 • Detailed market segmentation and market share analysis of each segment • Impact analysis of various drivers and trends • Market segmentation and landscape • Competitive landscape, 2017. Enteral Feeding Devices Market

Table of Contents

Clinical Laboratory Services Market

Chapter 1 Research Methodology 1.1. Research Methodology 1.2. Market definition 1.3. Assumptions and Acronyms Used 1.4. Data Sources 1.4.1. Secondary 1.4.1.1. Paid 1.4.1.2. Unpaid 1.4.2. Primary Chapter 2 Executive Summary 2.1. Global Clinical Laboratory Services Market overview 2.1.1. By Test Type 2.1.2. By Provider 2.1.3. By Applications Chapter 3 Global Clinical Laboratory Services Market Industry Insights 3.1. Market segmentation and scope of study 3.2. Market Drivers and their impact analysis 3.2.1. Market Drivers 3.2.1.1. Increasing rate of research and Development in medical sector 3.2.1.2. Rising concern pertaining to cost control 3.3. Market share analysis 3.3.1. By Test Type 3.3.2. By Provider 3.3.3. By Applications 3.4. Competitive analysis 3.4.1. Key strategic initiatives 3.4.2. Regional presence 3.4.3. Product overview 3.5. Porter’s analysis 3.6. PESTEL analysis Chapter 4 Clinical Laboratory Services Market, By Test Type 4.1 Key segment trends 4.2 Clinical Chemistry Testing 4.2.1.1 Market size, by region, 2013 - 2024 4.2.2 Routine Chemistry Testing 4.2.2.1 Market size, by region, 2013 – 2024 4.2.3 Endocrinology Chemistry Testing 4.2.3.1 Market size, by region, 2013 - 2024 4.2.4 Therapeutic Drug Monitoring (TDM) Testing 4.2.4.1 Market size, by region, 2013 - 2024 4.2.5 Specialized Chemistry Testing 4.2.5.1 Market size, by region, 2013 - 2024 4.2.6 Other Clinical Chemistry Testing 4.2.6.1 Market size, by region, 2013 - 2024 4.2.7 Microbiology Testing 4.2.7.1 Market size, by region, 2013 - 2024 4.2.8 Infectious Disease Testing 4.2.8.1 Market size, by region, 2013 – 2024 4.2.9 Transplant Diagnostic Testing 4.2.9.1 Market size, by region, 2013 – 2024 4.2.10 Other Microbiology Testing 4.2.10.1 Market size, by region, 2013 - 2024 4.2.11 Hematology Testing 4.2.11.1 Market size, by region, 2013 – 2024 4.2.12 Immunology Testing 4.2.12.1 Market size, by region, 2013 - 2024 4.2.13 Cytology Testing 4.2.13.1 Market size, by region, 2013 – 2024 4.2.14 Genetic Testing 4.2.14.1 Market size, by region, 2013 – 2024 4.2.15 Drug of Abuse Testing 4.2.15.1 Market size, by region, 2013 - 2024 Chapter 5 Clinical Laboratory Services Market, By Provider 5.1 Key segment trends 5.1.1 Hospital-Based Laboratories 5.1.1.1 Market size, by region, 2013 - 2024 5.1.2 Stand-Alone Laboratories 5.1.2.1 Market size, by region, 2013 – 2024 5.1.3 Clinic-Based Laboratories 5.1.3.1 Market size, by region, 2013 - 2024 Chapter 6 Clinical Laboratory Services Market, By Applications 6.1 Key segment trends 6.1.1 Drug discovery related Services 6.1.1.1 Market size, by region, 2013 - 2024 6.1.2 Drug development related services 6.1.2.1 Market size, by region, 2013 – 2024 6.1.3 Toxicology testing services 6.1.3.1 Market size, by region, 2013 - 2024 6.1.4 Cell & gene therapy related services 6.1.4.1 Market size, by region, 2013 – 2024 6.1.5 Preclinical & clinical trial related services 6.1.5.1 Market size, by region, 2013 – 2024 6.1.6 Other clinical laboratory services 6.1.6.1 Market size, by region, 2013 - 2024 Chapter 7 Clinical Laboratory Services Market, By Region 7.1 Key regional trends 7.1.1 North America 7.1.1.1 Market size, by country, 2013 – 2024 7.1.1.2 Market size, by test type, 2013 – 2024 7.1.1.3 Market size, by providers, 2013 – 2024 7.1.1.4 Market size, by applications, 2013 – 2024 7.1.2 U.S. 7.1.2.1 Market size, by test type, 2013 – 2024 7.1.2.2 Market size, by providers, 2013 – 2024 7.1.2.3 Market size, by applications, 2013 – 2024 7.1.2.4 7.1.3 Canada 7.1.3.1 Market size, by test type, 2013 – 2024 7.1.3.2 Market size, by providers, 2013 – 2024 7.1.3.3 Market size, by applications, 2013 – 2024 7.1.4 Europe 7.1.4.1 Market size, by country, 2013 – 2024 7.1.4.2 Market size, by test type, 2013 – 2024 7.1.4.3 Market size, by providers, 2013 – 2024 7.1.4.4 Market size, by applications, 2013 – 2024 7.1.5 Germany 7.1.5.1 Market size, by test type, 2013 – 2024 7.1.5.2 Market size, by providers, 2013 – 2024 7.1.5.3 Market size, by applications, 2013 – 2024 7.1.6 UK 7.1.6.1 Market size, by test type, 2013 – 2024 7.1.6.2 Market size, by providers, 2013 – 2024 7.1.6.3 Market size, by applications, 2013 – 2024 7.1.7 France 7.1.7.1 Market size, by test type, 2013 – 2024 7.1.7.2 Market size, by providers, 2013 – 2024 7.1.7.3 Market size, by applications, 2013 – 2024 7.1.8 Spain 7.1.8.1 Market size, by test type, 2013 – 2024 7.1.8.2 Market size, by providers, 2013 – 2024 7.1.8.3 Market size, by applications, 2013 – 2024 7.1.9 Italy 7.1.9.1 Market size, by test type, 2013 – 2024 7.1.9.2 Market size, by providers, 2013 – 2024 7.1.9.3 Market size, by applications, 2013 – 2024 7.1.10 Asia Pacific 7.1.10.1 Market size, by country, 2013 – 2024 7.1.10.2 Market size, by test type, 2013 – 2024 7.1.10.3 Market size, by providers, 2013 – 2024 7.1.10.4 Market size, by applications, 2013 – 2024 7.1.11 India 7.1.11.1 Market size, by test type, 2013 – 2024 7.1.11.2 Market size, by providers, 2013 – 2024 7.1.11.3 Market size, by applications, 2013 – 2024 7.1.12 China 7.1.12.1 Market size, by test type, 2013 – 2024 7.1.12.2 Market size, by providers, 2013 – 2024 7.1.12.3 Market size, by applications, 2013 – 2024 7.1.13 Japan 7.1.13.1 Market size, by test type, 2013 – 2024 7.1.13.2 Market size, by providers, 2013 – 2024 7.1.13.3 Market size, by applications, 2013 – 2024 7.1.14 Australia 7.1.14.1 Market size, by test type, 2013 – 2024 7.1.14.2 Market size, by providers, 2013 – 2024 7.1.14.3 Market size, by applications, 2013 – 2024 7.1.15 Latin America 7.1.15.1 Market size, by country, 2013 – 2024 7.1.15.2 Market size, by test type, 2013 – 2024 7.1.15.3 Market size, by providers, 2013 – 2024 7.1.15.4 Market size, by applications, 2013 – 2024 7.1.16 Argentina 7.1.16.1 Market size, by test type, 2013 – 2024 7.1.16.2 Market size, by providers, 2013 – 2024 7.1.16.3 Market size, by applications, 2013 – 2024 7.1.17 Brazil 7.1.17.1 Market size, by test type, 2013 – 2024 7.1.17.2 Market size, by providers, 2013 – 2024 7.1.17.3 Market size, by applications, 2013 – 2024 7.1.18 Mexico 7.1.18.1 Market size, by test type, 2013 – 2024 7.1.18.2 Market size, by providers, 2013 – 2024 7.1.18.3 Market size, by applications, 2013 – 2024 7.1.19 Middle East and Africa 7.1.19.1 Market size, by country, 2013 – 2024 7.1.19.2 Market size, by test type, 2013 – 2024 7.1.19.3 Market size, by providers, 2013 – 2024 7.1.19.4 Market size, by applications, 2013 – 2024 7.1.20 South Africa 7.1.20.1 Market size, by test type, 2013 – 2024 7.1.20.2 Market size, by providers, 2013 – 2024 7.1.20.3 Market size, by applications, 2013 – 2024 7.1.21 Saudi Arabia 7.1.21.1 Market size, by test type, 2013 – 2024 7.1.21.2 Market size, by providers, 2013 – 2024 7.1.21.3 Market size, by applications, 2013 – 2024 Chapter 8 Consolidations 8.1 Mergers and Acquisitions 8.1.1 Partnership, Joint Ventures and Strategic Alliances/Sales Agreements 8.1.2 Patent Analysis 8.1.3 Key players 8.1.3.1 Mayo Medical Laboratories 8.1.3.1.1 Company overview 8.1.3.1.2 Key financials 8.1.3.1.3 Product landscape 8.1.3.1.4 Strategic initiatives 8.1.3.1.5 SWOT analysis 8.1.3.2 Laboratory Corporation of America Holdings 8.1.3.2.1 Company overview 8.1.3.2.2 Key financials 8.1.3.2.3 Product landscape 8.1.3.2.4 Strategic initiatives 8.1.3.2.5 SWOT analysis 8.1.3.3 Quest Diagnostics Incorporated 8.1.3.3.1 Company overview 8.1.3.3.2 Key financials 8.1.3.3.3 Product landscape 8.1.3.3.4 Strategic initiatives 8.1.3.3.5 SWOT analysis 8.1.4 Spectra Laboratories Inc. 8.1.4.1.1 Company overview 8.1.4.1.2 Key financials 8.1.4.1.3 Product landscape 8.1.4.1.4 Strategic initiatives 8.1.4.1.5 SWOT analysis 8.1.5 DaVita Healthcare Partners 8.1.5.1.1 Company overview 8.1.5.1.2 Key financials 8.1.5.1.3 Product landscape 8.1.5.1.4 Strategic initiatives 8.1.5.1.5 SWOT analysis 8.1.6 Eurofins Scientific 8.1.6.1.1 Company overview 8.1.6.1.2 Key financials 8.1.6.1.3 Product landscape 8.1.6.1.4 Strategic initiatives 8.1.6.1.5 SWOT analysis 8.1.7 Unilabs 8.1.7.1.1 Company overview 8.1.7.1.2 Key financials 8.1.7.1.3 Product landscape 8.1.7.1.4 Strategic initiatives 8.1.7.1.5 SWOT analysis 8.1.8 SYNLAB International GmbH 8.1.8.1.1 Company overview 8.1.8.1.2 Key financials 8.1.8.1.3 Product landscape 8.1.8.1.4 Strategic initiatives 8.1.8.1.5 SWOT analysis 8.1.9 Bio-Reference Laboratories 8.1.9.1.1 Company overview 8.1.9.1.2 Key financials 8.1.9.1.3 Product landscape 8.1.9.1.4 Strategic initiatives 8.1.9.1.5 SWOT analysis 8.1.10 Sonic Healthcare Limited 8.1.10.1.1 Company overview 8.1.10.1.2 Key financials 8.1.10.1.3 Product landscape 8.1.10.1.4 Strategic initiatives 8.1.10.1.5 SWOT analysis 8.1.11 Clinical Reference Laboratory, Inc. 8.1.11.1.1 Company overview 8.1.11.1.2 Key financials 8.1.11.1.3 Product landscape 8.1.11.1.4 Strategic initiatives 8.1.11.1.5 SWOT analysis 8.1.12 Cerba HealthCare 8.1.12.1.1 Company overview 8.1.12.1.2 Key financials 8.1.12.1.3 Product landscape 8.1.12.1.4 Strategic initiatives 8.1.12.1.5 SWOT analysis 8.1.13 ACM Medical Laboratory 8.1.13.1.1 Company overview 8.1.13.1.2 Key financials 8.1.13.1.3 Product landscape 8.1.13.1.4 Strategic initiatives 8.1.13.1.5 SWOT analysis 8.1.14 ADICON Clinical Laboratory 8.1.14.1.1 Company overview 8.1.14.1.2 Key financials 8.1.14.1.3 Product landscape 8.1.14.1.4 Strategic initiatives 8.1.14.1.5 SWOT analysis 8.1.15 Amedes Holding GmbH 8.1.15.1.1 Company overview 8.1.15.1.2 Key financials 8.1.15.1.3 Product landscape 8.1.15.1.4 Strategic initiatives 8.1.15.1.5 SWOT analysis 8.1.16 Quest Diagnostics Incorporated 8.1.16.1.1 Company overview 8.1.16.1.2 Key financials 8.1.16.1.3 Product landscape 8.1.16.1.4 Strategic initiatives 8.1.16.1.5 SWOT analysis 8.1.17 Genomic Health Inc.

Inquiry Before Buying

Request Sample

About This Report

Report ID1404
Category Healthcare
Publisher Name
No of Pages
Total Views
Published Date
Contact Us
Call Now